Santhera Pharmaceuticals Holding AG (SANN.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
As of 03:23PM CEST. Market open.
Currency in CHF
Valuation measures4
| Market cap (intra-day) | 108.28M |
| Enterprise value | 148.12M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.87 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 28.69 |
| Enterprise value/EBITDA | -1.43 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.16 |
| 52-week change 3 | 31.30% |
| S&P500 52-week change 3 | 29.31% |
| 52-week high 3 | 14.62 |
| 52-week low 3 | 6.75 |
| 50-day moving average 3 | 9.47 |
| 200-day moving average 3 | 9.52 |
Share statistics
| Avg vol (3-month) 3 | 25.11k |
| Avg vol (10-day) 3 | 15.47k |
| Shares outstanding 5 | 11.68M |
| Implied shares outstanding 6 | 11.68M |
| Float 8 | 6.57M |
| % held by insiders 1 | 21.79% |
| % held by institutions 1 | 3.23% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 08 Sept 2022 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 03 Jul 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 52.99% |
| Operating margin (ttm) | 71.83% |
Management effectiveness
| Return on assets (ttm) | 36.86% |
| Return on equity (ttm) | 653.02% |
Income statement
| Revenue (ttm) | 103.38M |
| Revenue per share (ttm) | 9.14 |
| Quarterly revenue growth (yoy) | 8,030.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 54.16M |
| Net income avi to common (ttm) | 54.78M |
| Diluted EPS (ttm) | -8.63 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 30.37M |
| Total cash per share (mrq) | 2.68 |
| Total debt (mrq) | 21.55M |
| Total debt/equity (mrq) | 35.64% |
| Current ratio (mrq) | 0.79 |
| Book value per share (mrq) | 5.34 |
Cash flow statement
| Operating cash flow (ttm) | 47.62M |
| Levered free cash flow (ttm) | -10.58M |
© 2024 Yahoo. All rights reserved.